{
    "2018-12-05": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Study Throws New Light On Cardiovascular Effectiveness Of Diabetes Drug Victoza",
                "features": {
                    "keywords": [
                        "Study",
                        "Cardiovascular",
                        "Effectiveness",
                        "Diabetes",
                        "Victoza"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Novo Nordisk announces another $22M investment in Clayton",
                "features": {
                    "keywords": [
                        "Novo",
                        "Nordisk",
                        "investment",
                        "Clayton"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}